ADC Therapeutics SA (NYSE: ADCT) last traded at $0.997, up 3.80% on the session. The quote above updates while this page is open; the figures below are drawn from ADC Therapeutics SA’s own filings and are restated only when a new one is published.
ADC Therapeutics SA trades on NYSE under the ticker ADCT. Its market capitalisation is $127.23 million.
Valuation measures for ADC Therapeutics SA, derived from the latest quote and its most recent SEC filing.
| Market cap | $127.23M |
|---|---|
| Enterprise value | $415.71M |
| Price / sales | 1.60 |
| Beta | 1.33 |
Trailing-twelve-month figures tagged in ADC Therapeutics SA's XBRL filings with the SEC.
| Revenue (TTM) | $79.58M |
|---|---|
| Net income (TTM) | -$96.91M |
| EPS (TTM) | -$0.580 |
| Operating margin | -125.08% |
| Cash | $219.11M |
Range and volume for ADCT over the past 52 weeks.
| 52-week high | $4.98 |
|---|---|
| 52-week low | $0.780 |
| Volume | 938.3K |
| Average volume | 1.90M |
| Previous close | $0.960 |
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.